These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7038860)
1. [Malignant tumors in bearers of kidney grafts in immunosuppressive therapy]. Vollenweider A; Largiadèr F; Uhlschmid G; Binswanger U; Briner J Schweiz Med Wochenschr; 1982 Jan; 112(4):102-11. PubMed ID: 7038860 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
3. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T; Kapischke M; Busing M Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [TBL] [Abstract][Full Text] [Related]
5. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545 [TBL] [Abstract][Full Text] [Related]
6. Cancer in renal transplant recipients. Sakellariou G; Memmos D; Alexopoulos E; Tsobanelis T; Sinakos Z; Papadimitriou M Cancer Detect Prev; 1986; 9(3-4):389-93. PubMed ID: 3527417 [TBL] [Abstract][Full Text] [Related]
7. Management of tongue cancer in the patient who is systemically immunosuppressed: a preliminary report. Meng S; Jiamei L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):689-93. PubMed ID: 11113812 [TBL] [Abstract][Full Text] [Related]
8. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy. Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008 [TBL] [Abstract][Full Text] [Related]
9. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies. Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973 [TBL] [Abstract][Full Text] [Related]
12. [Long-term results in pancreas transplantation in diabetes in the pre-cyclosporin era]. Largiadèr F Schweiz Med Wochenschr; 1996 Aug; 126(34):1433-6. PubMed ID: 8848705 [TBL] [Abstract][Full Text] [Related]
13. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases. Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z Clin Transpl; 2006; ():395-8. PubMed ID: 18365395 [TBL] [Abstract][Full Text] [Related]
14. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients. Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659 [TBL] [Abstract][Full Text] [Related]
15. Melanomas in renal transplant recipients. Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778 [TBL] [Abstract][Full Text] [Related]
16. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Otley CC; Coldiron BM; Stasko T; Goldman GD Arch Dermatol; 2001 Apr; 137(4):459-63. PubMed ID: 11295926 [TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019 [TBL] [Abstract][Full Text] [Related]